New drug shows promise for heart attack recovery in early trial

NCT ID NCT05350969

Completed Disease control Sponsor: Cardior Pharmaceuticals GmbH Source: ClinicalTrials.gov ↗

First seen Apr 24, 2026 · Last updated May 12, 2026 · Updated 2 times

Summary

This study tested a new medicine called CDR132L in 294 people who had a recent heart attack and had weak heart pumping function. The goal was to see if the drug could safely improve heart function over 6 months, compared to a placebo. All participants continued their standard heart medications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

"Alexandra" General Hospital of Athens

Athens, Greece
"Attikon" General University Hospital

Athens, Greece
Complejo Hospitalario Universitario de Vigo

Vigo, Spain
D & A Research B.V.

Sneek, Netherlands
Deventer Ziekenhuis

Deventer, Netherlands
Erasmus University Medical Center

Rotterdam, Netherlands
Gabinet Internistyczno-Kardiologiczny Jacek Nowak

Libiąż, Poland
Gelderse Vallei Ziekenhuis

Ede, Netherlands
Gelre Ziekenhuizen

Zutphen, Netherlands
General University Hospital of Patras "Panagia i Voitheia"

Pátrai, Greece
Helios Klinikum Erfurt

Erfurt, Germany
Herzzentrum Dresden Universitätsklinik

Dresden, Germany
Hospital Clinico Universitario de Valencia

Valencia, Spain
Hospital Universitari Germans Trias i Pujol

Badalona, Spain
Hospital Universitario La Paz

Madrid, Spain
Hospital Universitario San Cecilio

Granada, Spain
Hospital Universitario Virgen Macarena

Seville, Spain
Hospital Universitario Virgen de la Arrixaca

Murcia, Spain
Hospital Universitario de Sabadell

Sabadell, Spain
Hospital de la Santa Creu I Sant Pau

Barcelona, Spain
Ikazia Ziekenhuis

Rotterdam, Netherlands
Institut klinicke a experimentalni mediciny

Prague, Czechia
Investigational Site

Wroclaw, Poland
Jeroen Bosch Ziekenhuis (JBZ) (Hieronymus Bosch Hospital) - locatie Den Bosch

's-Hertogenbosch, Netherlands
Klinikum Ludwigshafen

Ludwigshafen, Germany
Krakowski Szpital Specjalistyczny im. Jana Pawla II

Krakow, Poland
Medicome Sp. z o.o.

Oświęcim, Poland
Medisch Centrum Leeuwarden

Leeuwarden, Netherlands
Medizinische Hochschule Hannover

Hanover, Germany
NZOZ Pro-Cordis Sopockie Centrum Bad. Kardiolog

Sopot, Poland
NZOZ SALUS JZ Peruga

Lodz, Poland
One wojskowy Szpital Kliniczny w Lublinie

Lublin, Poland
Polsko Amerykanskie Kliniki Serca

Kędzierzyn-Koźle, Poland
Queen Elizabeth University Hospital

Glasgow, United Kingdom
Richmond Pharmacology Limited

London, United Kingdom
Semmelweis University

Budapest, Hungary
Slingeland Ziekenhuis

Doetinchem, Netherlands
South Tees Hospital NHS Foundation Trust

Middlesbrough, United Kingdom
Spec.Szpital im.dr Sokolowskiego

Wałbrzych, Poland
Specjalistyczna Poradnia Kardiologiczna i Nadcisnienia Tetniczego

Kielce, Poland
St. Jansdal Ziekenhuis

Lelystad, Netherlands
St. Marien-Krankenhaus Ahaus

Ahaus, Germany
Universitätsklinikum Schleswig-Holstein

Kiel, Germany
Universitätsklinikum Würzburg

Würzburg, Germany
Universitätsmedizin Göttingen

Göttingen, Germany
Všeobecná fakultní nemocnice v Praze

Prague, Czechia
Wojewodzki Szpital Zespolony

Torun, Poland
Wojewódzki Szpital im. Sw. Ojca Pio w Przemyslu

Przemyśl, Poland
Wycombe Hospital

High Wycombe, United Kingdom

Conditions

Explore the condition pages connected to this study.

HEART FAILURE, LEFT SIDED MYOCARDIAL INFARCTION, ACUTE